Global Implanted Central Venous Access Devices Market Growth 2025-2031

The global Implanted Central Venous Access Devices market size is predicted to grow from US$ 567 million in 2025 to US$ 681 million in 2031; it is expected to grow at a CAGR of 3.1% from 2025 to 2031.

Implanted Central Venous Access Devices (CVADs) are medical devices surgically placed under the skin to provide long-term venous access for patients requiring frequent or continuous intravenous therapy. These devices consist of a catheter inserted into a large central vein and a small port or reservoir placed under the skin, typically in the chest or upper arm. CVADs are commonly used for chemotherapy, long-term antibiotic therapy, parenteral nutrition, and other medical treatments. Their fully implanted design minimizes infection risks and enhances patient comfort compared to external catheters.

Key Features:

• Market Growth: The market is expected to grow from US$ 567 million in 2025 to US$ 681 million in 2031.
• Long-term venous access for medical treatments.
• Minimized infection risks and enhanced patient comfort.

Segmentation by Type:

• Titanium Implantable Port
• Plastic Implantable Port

Segmentation by Application:

• Intravenous Chemotherapy
• Nutritional Support Therapy

Market by Region:

• Americas
• APAC
• Europe
• Middle East & Africa

Companies Coverage:

• BD
• AngioDynamics
• ICU Medical
• B. Braun
• PFM Medical
• Vygon
• Districlass
• PakuMed
• Linhua Medical
• Fresenius
• Sophysa
• Baxter

Key Questions Addressed in this Report:

• What is the 10-year outlook for the global Implanted Central Venous Access Devices market?
• What factors are driving Implanted Central Venous Access Devices market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Implanted Central Venous Access Devices market opportunities vary by end market size?
• How does Implanted Central Venous Access Devices break out by Type, by Application?